Latest Advances in Drug Discovery & Development
eCheminfo InterAction Meeting
| Type |
Conference |
| Language |
English |
| Date |
October 16, 2006
to
October 19, 2006
|
| Venue |
Bryn Mawr College
101 N. Merion Avenue
Philadelphia,
PA
PA 19010-2899
US
|
| Chemistry Specialties |
- drug design and discovery
|
| Chemistry Techniques |
|
| Contact |
Barry Hardy
Douglas Connect
Baermeggenweg 14
Zeiningen,
CH-4314
CH
+41 61 851 0170
+44 870 112 38 44
echeminfo@innovationwell.net
|
| Add event to calendar |
vCal (Windows, Linux)
iCal (Mac OS X)
|
The eCheminfo InterAction meeting will discuss the latest developments in virtual screening, structure-based drug design, reaction planning, medicinal chemistry and predictive toxicology supporting decision making in drug discovery & development. The meeting brings together researchers, industry experts and managers, academics and solution providers with a common interest of improving the productivity and effectiveness of modeling and informatics methods in drug discovery, design and development. In addition to meeting presentations, significant time at meetings is reserved for panel discussions, workshops, and evening poster session and networking activities.
Sponsors
Johnson & Johnson PR&D, SimBioSys, CCG, Tripos, Symyx, ChemAxon, ACD/Labs, Rescentris, Leco, BlueGnome
Speakers
Zentam Tsuchihashi (Bristol-MyersSquibb), Peter Henstock (Pfizer), Darius Dziuda (Central Connecticut State Univ.), Keith Elliston (Genstruct), Bernd Bonnekoh (Otto-von-Guericke-University), Michael Jones (Novartis), Ansgar J. Pommer (SkinSysTec), Michael Liebman (Windber Research Institute), Jonathan Sheldon (InforSense), Duane Shugars (Concentia Digital), Jian Wang (Biofortis), Peter Gates (Johnson & Johnson PRD), Barry Hardy (Douglas Connect), Dennis Underwood (Praxeon), Jeff Spitzner (Rescentris), David Mosenkis (Spotfire), Joel Hoffman (Insightful), Delia Y. Wolf (Harvard Medical School), Craig Liddell (Realtime Science), Joseph Bitran (Enterprizer), Alvin Berger (Metabolon), Gregory Banik (Bio-RAD), George Harrigan (Monsanto), Rick Beger (NCTR, FDA), Don Robertson (Pfizer), Teresa Garret (Duke University), Laszlo Boros (SIDMAP), Bruce Kristal (Cornell University), Andrew N. Lane (JG Brown Cancer Center, U. Louisville), Nick Haan (BlueGnome), Oliver Fiehn (UC Davis Genome Center), Eric Nemec (Leco Corporation), Susan Connor (GlaxoSmithKline), Frank Hollinger (Locus Pharmaceuticals), Erin Duffy (Rib-X), Mike Malamas (Wyeth), Debananda Das (NCI), Max Cummings (Johnson & Johnson PRD), Jose Duca (Schering-Plough), Paul Labute (Chemical Computing Group), Lance Westerhoff (QuantumBio), Osman F. Güner (Turquoise Consulting), Hege Beard (Schrodinger), Zenon Konteatis (Locus Pharmaceuticals), Alex Clark (Chemical Computing Group), Stan Young (National Institute of Statistical Sciences), John Irwin (UCSF), William Douglas Figg (NCI), Daryll Reid (SimBioSys), Neysa Nevins (GlaxoSmithKline), Deepak Bandyopadhyay (Johnson & Johnson PRD), Paul Hawkins (OpenEye), Chris Cooper (BMS), James Arnold (Astra-Zeneca), Phil Edwards (Astra-Zeneca), Pete Connolly (Johnson & Johnson PRD), Victor Lobanov (Johnson & Johnson PRD), Jim Wikel (Coalesix), Tudor Oprea (Univ. New Mexico), Alex Tropsha (UNC), Curt Breneman (Rensselaer Polytechnic Institute), Sanji Bhal ( ACD/Labs), Michael B. Bolger (Simulations Plus), Bob Clark (Tripos), Gilles Klopman (Multicase), Navita Mallalieu (Roche Pharmaceuticals)
Session titles
Structure-based Drug Design, Screening, Bench Scientists’ & Modellers’ Discussions on Discovery Tools & Modeling, Predictive Toxicology plus InnovationWell sessions on Application of Metabolomics to Drug Discovery & Development, Biomarker Discovery & Applications in Drug Development, Decision Support for Research & Development, Utilising Knowledge Management to increase R&D Productivity along Critical Paths, and Electronic Laboratory Notebooks
Other topics
cheminformatics, medicinal chemistry
More information about this event…